Diamedica Therapeutics Inc. (DMAC)

Market is closed

Sector: Pharmaceutical Preparations

Hedge Fund Popularity

Display

Display Share Price

Hedge Fund Holdings

Filing Period:

Last updated on February 18, 2026, 7:49pm based on SEC 13F filings Last update: February 18, 2026, 7:49pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Omega Advisors Leon Cooperman	2,020,000	$16,079,200	-39%	0.53%
2.	Millennium Management Israel Englander	768,560	$6,117,738	-36%	0%
3.	Citadel Investment Group Ken Griffin	110,737	$881,467	+60%	0%
4.	Kalehua Capital Management Tai-Li Chang	95,359	$759,058		0.75%
5.	Private Capital Management Gregg J. Powers	50,000	$398,000		0.04%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Stahlberg Large Shareholder	$8.57	73,099	$626,816.62	8,825,742	2025-11-25	Filing
Stahlberg Large Shareholder	$7.89	40,253	$317,720.95	8,752,643	2025-11-24	Filing
Stahlberg Large Shareholder	$7.41	208,872	$1,547,574.42	8,712,390	2025-11-21	Filing
Stahlberg Large Shareholder	$7.41	128,426	$951,212.85	8,503,518	2025-11-20	Filing
Stahlberg Large Shareholder	$7.21	240,352	$1,732,361.08	8,375,092	2025-11-19	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Von Large Shareholder	$1.24	2,855,847	$3,526,971.05	0	2022-12-02	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	1,900,899	$15,131,156	0%
2.	Paragon Associates & Paragon Associates Ii Joint Venture	875,000	$6,965,000	14.39%
3.	Geode Capital Management, Llc	764,255	$6,084,946	0%
4.	Vanguard Group Inc	723,120	$5,756,035	0%
5.	State Street Corp	627,771	$4,997,057	0%